🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ampullary adenocarcinoma (AAC) is a rare gastrointestinal cancer with varyi...
Status
Recruiting
Location
Fondazione Poliambulanza
Start Date
2023-07-01
Trial ID
NCT06068023
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of an investigational...
Status
Recruiting
Location
The University of Arizona Cancer Center-North Campus
Start Date
2026-05-22
Trial ID
NCT07621718
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-01-10
Trial ID
NCT06149689
Treatments Being Tested
This is a study of the combination of 9 ING-41 (elraglusib) and retifanlima...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2025-09-22
Trial ID
NCT06896188
Treatments Being Tested
The main purpose of * To observe the overall survival of patients with res...
Status
Unknown
Location
Multiple Locations
Start Date
2021-04-01
Trial ID
NCT04835064
Treatments Being Tested
The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Status
Completed
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2019-04-01
Trial ID
NCT03983057
Treatments Being Tested
This is an open-label, phase 1/2, multiple-indication platform study to exp...
Status
Active Not Recruiting
Location
Nationales Centrum für Tumorerkrankungen Heidelberg
Start Date
2021-10-27
Trial ID
NCT07280377
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-04-01
Trial ID
NCT06249321
Treatments Being Tested
Ampullary adenocarcinoma (AMPAC) is a rare cancer (0.2% of digestive cancer...
Status
Recruiting
Location
CHU Dijon Bourgogne
Start Date
2025-07-02
Trial ID
NCT06813976
A Single-arm phase II trial evaluating induction chemotherapy with FOLFIRIN...
Status
Unknown
Location
Amel Mezlini
Start Date
2020-11-01
Trial ID
NCT05868317
Treatments Being Tested